Brief: HBM Holdings Says Entering Into License Agreement With Seagen
15/12/2023 01:24
Dec 15 (Reuters) - Hbm Holdings Ltd 2142.HK :
* ENTERING INTO LICENSE AGREEMENT WITH SEAGEN INC
* NONA BIOSCIENCES AND SEAGEN INC ENTERED INTO A LICENSE
AGREEMENT
* LICENSE AGREEMENT FOR GLOBAL CLINICAL DEVELOPMENT AND
COMMERCIALIZATION OF HBM9033
* AGGREGATE AMOUNT OF US$53 MLN UPFRONT AND NEAR-TERM
PAYMENT
Source text for Eikon: ID:
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study